LifeMine Therapeutics
Cambridge, USA· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
An AI-powered drug discovery company mining fungal genomes for novel, evolutionarily validated small molecule therapeutics.
OncologyImmunology
Technology Platform
The Avatar-Rx platform integrates fungal genomics, AI/ML, and synthetic biology to discover, characterize, and produce novel small molecule drugs from fungal DNA.
Opportunities
Potential to rapidly generate novel, biologically active drug candidates with high hit rates against difficult-to-drug targets in oncology and immunology.
Risk Factors
High technical risk in translating genomic predictions into viable, developable drugs, and potential challenges in scaling the platform and manufacturing complex natural product-derived molecules.
Competitive Landscape
Competes with other AI-driven drug discovery companies but is differentiated by its exclusive mining of the evolutionarily refined fungal chemical universe.